Duvyzat

givinostat

Approval

ApplicationNDA 217865
Approval dateMar 21, 2024
Approval year2024
SponsorItalfarmaco SPA

FDA-approved use

To treat Duchenne muscular dystrophy in individuals aged 6 years and older

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Duvyzat: